The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)
Advanced Search

Session Details

Symposium

[S17]Frontiers in Studies on Antiviral Infectious Diseases —Shaping Therapeutic Innovation through Target Molecules—

Thu. Mar 27, 2025 4:45 PM - 6:15 PM JST
Thu. Mar 27, 2025 7:45 AM - 9:15 AM UTC
Room 8 (Fukuoka International Congress Center: 409+410 [4F])
Organizer: Naoki Kishimoto (Grad. Sch. Pharm. Sci., kumamoto Univ), Hirokazu Tamamura (Lab. Biomat. Bioeng., Inst. Sci. Tokyo), Shogo Misumi (Grad. Sch. Pharm. Sci., Kumamoto Univ), Mikako Fujita (Grad. Sch. Pharm. Sci., Kumamoto Univ), Yasumasa Iwatani (NMC Nagoya Med. Ctr.)
4:45 PM - 4:50 PM JST(7:45 AM - 7:50 AM UTC)

オーガナイザー挨拶：岸本 直樹（熊本大院薬）

4:50 PM - 5:10 PM JST(7:50 AM - 8:10 AM UTC)

[S17-1]Drug discovery and development targeting SARS-CoV-2 main protease

○Nobuyo Higashi-Kuwata1, Shin-ichiro Hattori1, Naoki Kishimoto2, Nobutoki Takamune2, Hiromi Ogata-Aoki1,3, Haydar Bulut4, Shogo Misumi2, Hirokazu Tamamura5, Hiroaki Mitsuya1,4,6 (1. Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, 2. Graduate School of Pharmaceutical Sciences, Kumamoto University, 3. Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 4. Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, 5. Lab. Biomat. Bioeng., Inst. Sci. Tokyo, 6. Kumamoto University Hospital)
5:10 PM - 5:30 PM JST(8:10 AM - 8:30 AM UTC)

[S17-2]Identification of peptide-based hepatitis B virus capsid inhibitors based on the viral core protein

○Tetsuo Narumi1, Tetsuro Suzuki2 (1. Shizuoka Univ. Grad. Sch. of Integrated Sci. & Tech., 2. Hamamatsu Univ. Sch. of Med.)
5:30 PM - 5:50 PM JST(8:30 AM - 8:50 AM UTC)

[S17-3]Study toward HIV latency-reversing agents based on the natural product 'ansellone A'

○Kenichi Murai1 (1. School of Pharmaceutical Sciences, Wakayama Medical University)
5:50 PM - 6:10 PM JST(8:50 AM - 9:10 AM UTC)

[S17-4]Protective Immunity against Mucosal Pathogens: Administration route and inductive site of antiviral immunity.

○Ryotarou Mitsumata1 (1. Denka Vaccine Research)
6:10 PM - 6:15 PM JST(9:10 AM - 9:15 AM UTC)

総括：三隅 将吾（熊本大院薬）

Back to Category List